CRISPR Gene Detection and Diagnostic Market, Global Outlook and Forecast 2022-2028
This report contains market size and forecasts of CRISPR Gene Detection and Diagnostic in Global, including the following market information:
Global CRISPR Gene Detection and Diagnostic Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global CRISPR Gene Detection and Diagnostic market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Cutting Function Detection Method Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of CRISPR Gene Detection and Diagnostic include Roche Molecular Diagnostics, Sherlock Biosciences, Thermo Fisher Scientific Inc., Aelian Biotechnology, Vivlion, Beckman Coulter Diagnostics, Binx Health, bioM?rieux Diagnostics and Caspr Biotech, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the CRISPR Gene Detection and Diagnostic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global CRISPR Gene Detection and Diagnostic Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global CRISPR Gene Detection and Diagnostic Market Segment Percentages, by Type, 2021 (%)
Global CRISPR Gene Detection and Diagnostic Market Segment Percentages, by Application, 2021 (%)
Global CRISPR Gene Detection and Diagnostic Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies CRISPR Gene Detection and Diagnostic revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies CRISPR Gene Detection and Diagnostic revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global CRISPR Gene Detection and Diagnostic Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global CRISPR Gene Detection and Diagnostic market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Cutting Function Detection Method Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of CRISPR Gene Detection and Diagnostic include Roche Molecular Diagnostics, Sherlock Biosciences, Thermo Fisher Scientific Inc., Aelian Biotechnology, Vivlion, Beckman Coulter Diagnostics, Binx Health, bioM?rieux Diagnostics and Caspr Biotech, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the CRISPR Gene Detection and Diagnostic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global CRISPR Gene Detection and Diagnostic Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global CRISPR Gene Detection and Diagnostic Market Segment Percentages, by Type, 2021 (%)
- Cutting Function Detection Method
- Positioning Function Detection Method
Global CRISPR Gene Detection and Diagnostic Market Segment Percentages, by Application, 2021 (%)
- Hospitals
- Clinics
- Others
Global CRISPR Gene Detection and Diagnostic Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies CRISPR Gene Detection and Diagnostic revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies CRISPR Gene Detection and Diagnostic revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Roche Molecular Diagnostics
- Sherlock Biosciences
- Thermo Fisher Scientific Inc.
- Aelian Biotechnology
- Vivlion
- Beckman Coulter Diagnostics
- Binx Health
- bioM?rieux Diagnostics
- Caspr Biotech
- Agilent
- Axxam
- ERS Genomics
- FASMAC
- Illumina
- Janssen Diagnostics
- Locus Biosciences
- Mammoth Biosciences
- NRGene
- Bio-Rad Laboratories, Inc
- 10x Genomics, Inc.
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 CRISPR Gene Detection and Diagnostic Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global CRISPR Gene Detection and Diagnostic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL CRISPR GENE DETECTION AND DIAGNOSTIC OVERALL MARKET SIZE
2.1 Global CRISPR Gene Detection and Diagnostic Market Size: 2021 VS 2028
2.2 Global CRISPR Gene Detection and Diagnostic Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top CRISPR Gene Detection and Diagnostic Players in Global Market
3.2 Top Global CRISPR Gene Detection and Diagnostic Companies Ranked by Revenue
3.3 Global CRISPR Gene Detection and Diagnostic Revenue by Companies
3.4 Top 3 and Top 5 CRISPR Gene Detection and Diagnostic Companies in Global Market, by Revenue in 2021
3.5 Global Companies CRISPR Gene Detection and Diagnostic Product Type
3.6 Tier 1, Tier 2 and Tier 3 CRISPR Gene Detection and Diagnostic Players in Global Market
3.6.1 List of Global Tier 1 CRISPR Gene Detection and Diagnostic Companies
3.6.2 List of Global Tier 2 and Tier 3 CRISPR Gene Detection and Diagnostic Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global CRISPR Gene Detection and Diagnostic Market Size Markets, 2021 & 2028
4.1.2 Cutting Function Detection Method
4.1.3 Positioning Function Detection Method
4.2 By Type - Global CRISPR Gene Detection and Diagnostic Revenue & Forecasts
4.2.1 By Type - Global CRISPR Gene Detection and Diagnostic Revenue, 2017-2022
4.2.2 By Type - Global CRISPR Gene Detection and Diagnostic Revenue, 2023-2028
4.2.3 By Type - Global CRISPR Gene Detection and Diagnostic Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global CRISPR Gene Detection and Diagnostic Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global CRISPR Gene Detection and Diagnostic Revenue & Forecasts
5.2.1 By Application - Global CRISPR Gene Detection and Diagnostic Revenue, 2017-2022
5.2.2 By Application - Global CRISPR Gene Detection and Diagnostic Revenue, 2023-2028
5.2.3 By Application - Global CRISPR Gene Detection and Diagnostic Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global CRISPR Gene Detection and Diagnostic Market Size, 2021 & 2028
6.2 By Region - Global CRISPR Gene Detection and Diagnostic Revenue & Forecasts
6.2.1 By Region - Global CRISPR Gene Detection and Diagnostic Revenue, 2017-2022
6.2.2 By Region - Global CRISPR Gene Detection and Diagnostic Revenue, 2023-2028
6.2.3 By Region - Global CRISPR Gene Detection and Diagnostic Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America CRISPR Gene Detection and Diagnostic Revenue, 2017-2028
6.3.2 US CRISPR Gene Detection and Diagnostic Market Size, 2017-2028
6.3.3 Canada CRISPR Gene Detection and Diagnostic Market Size, 2017-2028
6.3.4 Mexico CRISPR Gene Detection and Diagnostic Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe CRISPR Gene Detection and Diagnostic Revenue, 2017-2028
6.4.2 Germany CRISPR Gene Detection and Diagnostic Market Size, 2017-2028
6.4.3 France CRISPR Gene Detection and Diagnostic Market Size, 2017-2028
6.4.4 U.K. CRISPR Gene Detection and Diagnostic Market Size, 2017-2028
6.4.5 Italy CRISPR Gene Detection and Diagnostic Market Size, 2017-2028
6.4.6 Russia CRISPR Gene Detection and Diagnostic Market Size, 2017-2028
6.4.7 Nordic Countries CRISPR Gene Detection and Diagnostic Market Size, 2017-2028
6.4.8 Benelux CRISPR Gene Detection and Diagnostic Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia CRISPR Gene Detection and Diagnostic Revenue, 2017-2028
6.5.2 China CRISPR Gene Detection and Diagnostic Market Size, 2017-2028
6.5.3 Japan CRISPR Gene Detection and Diagnostic Market Size, 2017-2028
6.5.4 South Korea CRISPR Gene Detection and Diagnostic Market Size, 2017-2028
6.5.5 Southeast Asia CRISPR Gene Detection and Diagnostic Market Size, 2017-2028
6.5.6 India CRISPR Gene Detection and Diagnostic Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America CRISPR Gene Detection and Diagnostic Revenue, 2017-2028
6.6.2 Brazil CRISPR Gene Detection and Diagnostic Market Size, 2017-2028
6.6.3 Argentina CRISPR Gene Detection and Diagnostic Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa CRISPR Gene Detection and Diagnostic Revenue, 2017-2028
6.7.2 Turkey CRISPR Gene Detection and Diagnostic Market Size, 2017-2028
6.7.3 Israel CRISPR Gene Detection and Diagnostic Market Size, 2017-2028
6.7.4 Saudi Arabia CRISPR Gene Detection and Diagnostic Market Size, 2017-2028
6.7.5 UAE CRISPR Gene Detection and Diagnostic Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Roche Molecular Diagnostics
7.1.1 Roche Molecular Diagnostics Corporate Summary
7.1.2 Roche Molecular Diagnostics Business Overview
7.1.3 Roche Molecular Diagnostics CRISPR Gene Detection and Diagnostic Major Product Offerings
7.1.4 Roche Molecular Diagnostics CRISPR Gene Detection and Diagnostic Revenue in Global Market (2017-2022)
7.1.5 Roche Molecular Diagnostics Key News
7.2 Sherlock Biosciences
7.2.1 Sherlock Biosciences Corporate Summary
7.2.2 Sherlock Biosciences Business Overview
7.2.3 Sherlock Biosciences CRISPR Gene Detection and Diagnostic Major Product Offerings
7.2.4 Sherlock Biosciences CRISPR Gene Detection and Diagnostic Revenue in Global Market (2017-2022)
7.2.5 Sherlock Biosciences Key News
7.3 Thermo Fisher Scientific Inc.
7.3.1 Thermo Fisher Scientific Inc. Corporate Summary
7.3.2 Thermo Fisher Scientific Inc. Business Overview
7.3.3 Thermo Fisher Scientific Inc. CRISPR Gene Detection and Diagnostic Major Product Offerings
7.3.4 Thermo Fisher Scientific Inc. CRISPR Gene Detection and Diagnostic Revenue in Global Market (2017-2022)
7.3.5 Thermo Fisher Scientific Inc. Key News
7.4 Aelian Biotechnology
7.4.1 Aelian Biotechnology Corporate Summary
7.4.2 Aelian Biotechnology Business Overview
7.4.3 Aelian Biotechnology CRISPR Gene Detection and Diagnostic Major Product Offerings
7.4.4 Aelian Biotechnology CRISPR Gene Detection and Diagnostic Revenue in Global Market (2017-2022)
7.4.5 Aelian Biotechnology Key News
7.5 Vivlion
7.5.1 Vivlion Corporate Summary
7.5.2 Vivlion Business Overview
7.5.3 Vivlion CRISPR Gene Detection and Diagnostic Major Product Offerings
7.5.4 Vivlion CRISPR Gene Detection and Diagnostic Revenue in Global Market (2017-2022)
7.5.5 Vivlion Key News
7.6 Beckman Coulter Diagnostics
7.6.1 Beckman Coulter Diagnostics Corporate Summary
7.6.2 Beckman Coulter Diagnostics Business Overview
7.6.3 Beckman Coulter Diagnostics CRISPR Gene Detection and Diagnostic Major Product Offerings
7.6.4 Beckman Coulter Diagnostics CRISPR Gene Detection and Diagnostic Revenue in Global Market (2017-2022)
7.6.5 Beckman Coulter Diagnostics Key News
7.7 Binx Health
7.7.1 Binx Health Corporate Summary
7.7.2 Binx Health Business Overview
7.7.3 Binx Health CRISPR Gene Detection and Diagnostic Major Product Offerings
7.7.4 Binx Health CRISPR Gene Detection and Diagnostic Revenue in Global Market (2017-2022)
7.7.5 Binx Health Key News
7.8 bioM?rieux Diagnostics
7.8.1 bioM?rieux Diagnostics Corporate Summary
7.8.2 bioM?rieux Diagnostics Business Overview
7.8.3 bioM?rieux Diagnostics CRISPR Gene Detection and Diagnostic Major Product Offerings
7.8.4 bioM?rieux Diagnostics CRISPR Gene Detection and Diagnostic Revenue in Global Market (2017-2022)
7.8.5 bioM?rieux Diagnostics Key News
7.9 Caspr Biotech
7.9.1 Caspr Biotech Corporate Summary
7.9.2 Caspr Biotech Business Overview
7.9.3 Caspr Biotech CRISPR Gene Detection and Diagnostic Major Product Offerings
7.9.4 Caspr Biotech CRISPR Gene Detection and Diagnostic Revenue in Global Market (2017-2022)
7.9.5 Caspr Biotech Key News
7.10 Agilent
7.10.1 Agilent Corporate Summary
7.10.2 Agilent Business Overview
7.10.3 Agilent CRISPR Gene Detection and Diagnostic Major Product Offerings
7.10.4 Agilent CRISPR Gene Detection and Diagnostic Revenue in Global Market (2017-2022)
7.10.5 Agilent Key News
7.11 Axxam
7.11.1 Axxam Corporate Summary
7.11.2 Axxam Business Overview
7.11.3 Axxam CRISPR Gene Detection and Diagnostic Major Product Offerings
7.11.4 Axxam CRISPR Gene Detection and Diagnostic Revenue in Global Market (2017-2022)
7.11.5 Axxam Key News
7.12 ERS Genomics
7.12.1 ERS Genomics Corporate Summary
7.12.2 ERS Genomics Business Overview
7.12.3 ERS Genomics CRISPR Gene Detection and Diagnostic Major Product Offerings
7.12.4 ERS Genomics CRISPR Gene Detection and Diagnostic Revenue in Global Market (2017-2022)
7.12.5 ERS Genomics Key News
7.13 FASMAC
7.13.1 FASMAC Corporate Summary
7.13.2 FASMAC Business Overview
7.13.3 FASMAC CRISPR Gene Detection and Diagnostic Major Product Offerings
7.13.4 FASMAC CRISPR Gene Detection and Diagnostic Revenue in Global Market (2017-2022)
7.13.5 FASMAC Key News
7.14 Illumina
7.14.1 Illumina Corporate Summary
7.14.2 Illumina Business Overview
7.14.3 Illumina CRISPR Gene Detection and Diagnostic Major Product Offerings
7.14.4 Illumina CRISPR Gene Detection and Diagnostic Revenue in Global Market (2017-2022)
7.14.5 Illumina Key News
7.15 Janssen Diagnostics
7.15.1 Janssen Diagnostics Corporate Summary
7.15.2 Janssen Diagnostics Business Overview
7.15.3 Janssen Diagnostics CRISPR Gene Detection and Diagnostic Major Product Offerings
7.15.4 Janssen Diagnostics CRISPR Gene Detection and Diagnostic Revenue in Global Market (2017-2022)
7.15.5 Janssen Diagnostics Key News
7.16 Locus Biosciences
7.16.1 Locus Biosciences Corporate Summary
7.16.2 Locus Biosciences Business Overview
7.16.3 Locus Biosciences CRISPR Gene Detection and Diagnostic Major Product Offerings
7.16.4 Locus Biosciences CRISPR Gene Detection and Diagnostic Revenue in Global Market (2017-2022)
7.16.5 Locus Biosciences Key News
7.17 Mammoth Biosciences
7.17.1 Mammoth Biosciences Corporate Summary
7.17.2 Mammoth Biosciences Business Overview
7.17.3 Mammoth Biosciences CRISPR Gene Detection and Diagnostic Major Product Offerings
7.17.4 Mammoth Biosciences CRISPR Gene Detection and Diagnostic Revenue in Global Market (2017-2022)
7.17.5 Mammoth Biosciences Key News
7.18 NRGene
7.18.1 NRGene Corporate Summary
7.18.2 NRGene Business Overview
7.18.3 NRGene CRISPR Gene Detection and Diagnostic Major Product Offerings
7.18.4 NRGene CRISPR Gene Detection and Diagnostic Revenue in Global Market (2017-2022)
7.18.5 NRGene Key News
7.19 Bio-Rad Laboratories, Inc
7.19.1 Bio-Rad Laboratories, Inc Corporate Summary
7.19.2 Bio-Rad Laboratories, Inc Business Overview
7.19.3 Bio-Rad Laboratories, Inc CRISPR Gene Detection and Diagnostic Major Product Offerings
7.19.4 Bio-Rad Laboratories, Inc CRISPR Gene Detection and Diagnostic Revenue in Global Market (2017-2022)
7.19.5 Bio-Rad Laboratories, Inc Key News
7.20 10x Genomics, Inc.
7.20.1 10x Genomics, Inc. Corporate Summary
7.20.2 10x Genomics, Inc. Business Overview
7.20.3 10x Genomics, Inc. CRISPR Gene Detection and Diagnostic Major Product Offerings
7.20.4 10x Genomics, Inc. CRISPR Gene Detection and Diagnostic Revenue in Global Market (2017-2022)
7.20.5 10x Genomics, Inc. Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 CRISPR Gene Detection and Diagnostic Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global CRISPR Gene Detection and Diagnostic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL CRISPR GENE DETECTION AND DIAGNOSTIC OVERALL MARKET SIZE
2.1 Global CRISPR Gene Detection and Diagnostic Market Size: 2021 VS 2028
2.2 Global CRISPR Gene Detection and Diagnostic Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top CRISPR Gene Detection and Diagnostic Players in Global Market
3.2 Top Global CRISPR Gene Detection and Diagnostic Companies Ranked by Revenue
3.3 Global CRISPR Gene Detection and Diagnostic Revenue by Companies
3.4 Top 3 and Top 5 CRISPR Gene Detection and Diagnostic Companies in Global Market, by Revenue in 2021
3.5 Global Companies CRISPR Gene Detection and Diagnostic Product Type
3.6 Tier 1, Tier 2 and Tier 3 CRISPR Gene Detection and Diagnostic Players in Global Market
3.6.1 List of Global Tier 1 CRISPR Gene Detection and Diagnostic Companies
3.6.2 List of Global Tier 2 and Tier 3 CRISPR Gene Detection and Diagnostic Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global CRISPR Gene Detection and Diagnostic Market Size Markets, 2021 & 2028
4.1.2 Cutting Function Detection Method
4.1.3 Positioning Function Detection Method
4.2 By Type - Global CRISPR Gene Detection and Diagnostic Revenue & Forecasts
4.2.1 By Type - Global CRISPR Gene Detection and Diagnostic Revenue, 2017-2022
4.2.2 By Type - Global CRISPR Gene Detection and Diagnostic Revenue, 2023-2028
4.2.3 By Type - Global CRISPR Gene Detection and Diagnostic Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global CRISPR Gene Detection and Diagnostic Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global CRISPR Gene Detection and Diagnostic Revenue & Forecasts
5.2.1 By Application - Global CRISPR Gene Detection and Diagnostic Revenue, 2017-2022
5.2.2 By Application - Global CRISPR Gene Detection and Diagnostic Revenue, 2023-2028
5.2.3 By Application - Global CRISPR Gene Detection and Diagnostic Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global CRISPR Gene Detection and Diagnostic Market Size, 2021 & 2028
6.2 By Region - Global CRISPR Gene Detection and Diagnostic Revenue & Forecasts
6.2.1 By Region - Global CRISPR Gene Detection and Diagnostic Revenue, 2017-2022
6.2.2 By Region - Global CRISPR Gene Detection and Diagnostic Revenue, 2023-2028
6.2.3 By Region - Global CRISPR Gene Detection and Diagnostic Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America CRISPR Gene Detection and Diagnostic Revenue, 2017-2028
6.3.2 US CRISPR Gene Detection and Diagnostic Market Size, 2017-2028
6.3.3 Canada CRISPR Gene Detection and Diagnostic Market Size, 2017-2028
6.3.4 Mexico CRISPR Gene Detection and Diagnostic Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe CRISPR Gene Detection and Diagnostic Revenue, 2017-2028
6.4.2 Germany CRISPR Gene Detection and Diagnostic Market Size, 2017-2028
6.4.3 France CRISPR Gene Detection and Diagnostic Market Size, 2017-2028
6.4.4 U.K. CRISPR Gene Detection and Diagnostic Market Size, 2017-2028
6.4.5 Italy CRISPR Gene Detection and Diagnostic Market Size, 2017-2028
6.4.6 Russia CRISPR Gene Detection and Diagnostic Market Size, 2017-2028
6.4.7 Nordic Countries CRISPR Gene Detection and Diagnostic Market Size, 2017-2028
6.4.8 Benelux CRISPR Gene Detection and Diagnostic Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia CRISPR Gene Detection and Diagnostic Revenue, 2017-2028
6.5.2 China CRISPR Gene Detection and Diagnostic Market Size, 2017-2028
6.5.3 Japan CRISPR Gene Detection and Diagnostic Market Size, 2017-2028
6.5.4 South Korea CRISPR Gene Detection and Diagnostic Market Size, 2017-2028
6.5.5 Southeast Asia CRISPR Gene Detection and Diagnostic Market Size, 2017-2028
6.5.6 India CRISPR Gene Detection and Diagnostic Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America CRISPR Gene Detection and Diagnostic Revenue, 2017-2028
6.6.2 Brazil CRISPR Gene Detection and Diagnostic Market Size, 2017-2028
6.6.3 Argentina CRISPR Gene Detection and Diagnostic Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa CRISPR Gene Detection and Diagnostic Revenue, 2017-2028
6.7.2 Turkey CRISPR Gene Detection and Diagnostic Market Size, 2017-2028
6.7.3 Israel CRISPR Gene Detection and Diagnostic Market Size, 2017-2028
6.7.4 Saudi Arabia CRISPR Gene Detection and Diagnostic Market Size, 2017-2028
6.7.5 UAE CRISPR Gene Detection and Diagnostic Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Roche Molecular Diagnostics
7.1.1 Roche Molecular Diagnostics Corporate Summary
7.1.2 Roche Molecular Diagnostics Business Overview
7.1.3 Roche Molecular Diagnostics CRISPR Gene Detection and Diagnostic Major Product Offerings
7.1.4 Roche Molecular Diagnostics CRISPR Gene Detection and Diagnostic Revenue in Global Market (2017-2022)
7.1.5 Roche Molecular Diagnostics Key News
7.2 Sherlock Biosciences
7.2.1 Sherlock Biosciences Corporate Summary
7.2.2 Sherlock Biosciences Business Overview
7.2.3 Sherlock Biosciences CRISPR Gene Detection and Diagnostic Major Product Offerings
7.2.4 Sherlock Biosciences CRISPR Gene Detection and Diagnostic Revenue in Global Market (2017-2022)
7.2.5 Sherlock Biosciences Key News
7.3 Thermo Fisher Scientific Inc.
7.3.1 Thermo Fisher Scientific Inc. Corporate Summary
7.3.2 Thermo Fisher Scientific Inc. Business Overview
7.3.3 Thermo Fisher Scientific Inc. CRISPR Gene Detection and Diagnostic Major Product Offerings
7.3.4 Thermo Fisher Scientific Inc. CRISPR Gene Detection and Diagnostic Revenue in Global Market (2017-2022)
7.3.5 Thermo Fisher Scientific Inc. Key News
7.4 Aelian Biotechnology
7.4.1 Aelian Biotechnology Corporate Summary
7.4.2 Aelian Biotechnology Business Overview
7.4.3 Aelian Biotechnology CRISPR Gene Detection and Diagnostic Major Product Offerings
7.4.4 Aelian Biotechnology CRISPR Gene Detection and Diagnostic Revenue in Global Market (2017-2022)
7.4.5 Aelian Biotechnology Key News
7.5 Vivlion
7.5.1 Vivlion Corporate Summary
7.5.2 Vivlion Business Overview
7.5.3 Vivlion CRISPR Gene Detection and Diagnostic Major Product Offerings
7.5.4 Vivlion CRISPR Gene Detection and Diagnostic Revenue in Global Market (2017-2022)
7.5.5 Vivlion Key News
7.6 Beckman Coulter Diagnostics
7.6.1 Beckman Coulter Diagnostics Corporate Summary
7.6.2 Beckman Coulter Diagnostics Business Overview
7.6.3 Beckman Coulter Diagnostics CRISPR Gene Detection and Diagnostic Major Product Offerings
7.6.4 Beckman Coulter Diagnostics CRISPR Gene Detection and Diagnostic Revenue in Global Market (2017-2022)
7.6.5 Beckman Coulter Diagnostics Key News
7.7 Binx Health
7.7.1 Binx Health Corporate Summary
7.7.2 Binx Health Business Overview
7.7.3 Binx Health CRISPR Gene Detection and Diagnostic Major Product Offerings
7.7.4 Binx Health CRISPR Gene Detection and Diagnostic Revenue in Global Market (2017-2022)
7.7.5 Binx Health Key News
7.8 bioM?rieux Diagnostics
7.8.1 bioM?rieux Diagnostics Corporate Summary
7.8.2 bioM?rieux Diagnostics Business Overview
7.8.3 bioM?rieux Diagnostics CRISPR Gene Detection and Diagnostic Major Product Offerings
7.8.4 bioM?rieux Diagnostics CRISPR Gene Detection and Diagnostic Revenue in Global Market (2017-2022)
7.8.5 bioM?rieux Diagnostics Key News
7.9 Caspr Biotech
7.9.1 Caspr Biotech Corporate Summary
7.9.2 Caspr Biotech Business Overview
7.9.3 Caspr Biotech CRISPR Gene Detection and Diagnostic Major Product Offerings
7.9.4 Caspr Biotech CRISPR Gene Detection and Diagnostic Revenue in Global Market (2017-2022)
7.9.5 Caspr Biotech Key News
7.10 Agilent
7.10.1 Agilent Corporate Summary
7.10.2 Agilent Business Overview
7.10.3 Agilent CRISPR Gene Detection and Diagnostic Major Product Offerings
7.10.4 Agilent CRISPR Gene Detection and Diagnostic Revenue in Global Market (2017-2022)
7.10.5 Agilent Key News
7.11 Axxam
7.11.1 Axxam Corporate Summary
7.11.2 Axxam Business Overview
7.11.3 Axxam CRISPR Gene Detection and Diagnostic Major Product Offerings
7.11.4 Axxam CRISPR Gene Detection and Diagnostic Revenue in Global Market (2017-2022)
7.11.5 Axxam Key News
7.12 ERS Genomics
7.12.1 ERS Genomics Corporate Summary
7.12.2 ERS Genomics Business Overview
7.12.3 ERS Genomics CRISPR Gene Detection and Diagnostic Major Product Offerings
7.12.4 ERS Genomics CRISPR Gene Detection and Diagnostic Revenue in Global Market (2017-2022)
7.12.5 ERS Genomics Key News
7.13 FASMAC
7.13.1 FASMAC Corporate Summary
7.13.2 FASMAC Business Overview
7.13.3 FASMAC CRISPR Gene Detection and Diagnostic Major Product Offerings
7.13.4 FASMAC CRISPR Gene Detection and Diagnostic Revenue in Global Market (2017-2022)
7.13.5 FASMAC Key News
7.14 Illumina
7.14.1 Illumina Corporate Summary
7.14.2 Illumina Business Overview
7.14.3 Illumina CRISPR Gene Detection and Diagnostic Major Product Offerings
7.14.4 Illumina CRISPR Gene Detection and Diagnostic Revenue in Global Market (2017-2022)
7.14.5 Illumina Key News
7.15 Janssen Diagnostics
7.15.1 Janssen Diagnostics Corporate Summary
7.15.2 Janssen Diagnostics Business Overview
7.15.3 Janssen Diagnostics CRISPR Gene Detection and Diagnostic Major Product Offerings
7.15.4 Janssen Diagnostics CRISPR Gene Detection and Diagnostic Revenue in Global Market (2017-2022)
7.15.5 Janssen Diagnostics Key News
7.16 Locus Biosciences
7.16.1 Locus Biosciences Corporate Summary
7.16.2 Locus Biosciences Business Overview
7.16.3 Locus Biosciences CRISPR Gene Detection and Diagnostic Major Product Offerings
7.16.4 Locus Biosciences CRISPR Gene Detection and Diagnostic Revenue in Global Market (2017-2022)
7.16.5 Locus Biosciences Key News
7.17 Mammoth Biosciences
7.17.1 Mammoth Biosciences Corporate Summary
7.17.2 Mammoth Biosciences Business Overview
7.17.3 Mammoth Biosciences CRISPR Gene Detection and Diagnostic Major Product Offerings
7.17.4 Mammoth Biosciences CRISPR Gene Detection and Diagnostic Revenue in Global Market (2017-2022)
7.17.5 Mammoth Biosciences Key News
7.18 NRGene
7.18.1 NRGene Corporate Summary
7.18.2 NRGene Business Overview
7.18.3 NRGene CRISPR Gene Detection and Diagnostic Major Product Offerings
7.18.4 NRGene CRISPR Gene Detection and Diagnostic Revenue in Global Market (2017-2022)
7.18.5 NRGene Key News
7.19 Bio-Rad Laboratories, Inc
7.19.1 Bio-Rad Laboratories, Inc Corporate Summary
7.19.2 Bio-Rad Laboratories, Inc Business Overview
7.19.3 Bio-Rad Laboratories, Inc CRISPR Gene Detection and Diagnostic Major Product Offerings
7.19.4 Bio-Rad Laboratories, Inc CRISPR Gene Detection and Diagnostic Revenue in Global Market (2017-2022)
7.19.5 Bio-Rad Laboratories, Inc Key News
7.20 10x Genomics, Inc.
7.20.1 10x Genomics, Inc. Corporate Summary
7.20.2 10x Genomics, Inc. Business Overview
7.20.3 10x Genomics, Inc. CRISPR Gene Detection and Diagnostic Major Product Offerings
7.20.4 10x Genomics, Inc. CRISPR Gene Detection and Diagnostic Revenue in Global Market (2017-2022)
7.20.5 10x Genomics, Inc. Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. CRISPR Gene Detection and Diagnostic Market Opportunities & Trends in Global Market
Table 2. CRISPR Gene Detection and Diagnostic Market Drivers in Global Market
Table 3. CRISPR Gene Detection and Diagnostic Market Restraints in Global Market
Table 4. Key Players of CRISPR Gene Detection and Diagnostic in Global Market
Table 5. Top CRISPR Gene Detection and Diagnostic Players in Global Market, Ranking by Revenue (2021)
Table 6. Global CRISPR Gene Detection and Diagnostic Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global CRISPR Gene Detection and Diagnostic Revenue Share by Companies, 2017-2022
Table 8. Global Companies CRISPR Gene Detection and Diagnostic Product Type
Table 9. List of Global Tier 1 CRISPR Gene Detection and Diagnostic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 CRISPR Gene Detection and Diagnostic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - CRISPR Gene Detection and Diagnostic Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - CRISPR Gene Detection and Diagnostic Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - CRISPR Gene Detection and Diagnostic Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - CRISPR Gene Detection and Diagnostic Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global CRISPR Gene Detection and Diagnostic Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global CRISPR Gene Detection and Diagnostic Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2023-2028
Table 30. Roche Molecular Diagnostics Corporate Summary
Table 31. Roche Molecular Diagnostics CRISPR Gene Detection and Diagnostic Product Offerings
Table 32. Roche Molecular Diagnostics CRISPR Gene Detection and Diagnostic Revenue (US$, Mn), (2017-2022)
Table 33. Sherlock Biosciences Corporate Summary
Table 34. Sherlock Biosciences CRISPR Gene Detection and Diagnostic Product Offerings
Table 35. Sherlock Biosciences CRISPR Gene Detection and Diagnostic Revenue (US$, Mn), (2017-2022)
Table 36. Thermo Fisher Scientific Inc. Corporate Summary
Table 37. Thermo Fisher Scientific Inc. CRISPR Gene Detection and Diagnostic Product Offerings
Table 38. Thermo Fisher Scientific Inc. CRISPR Gene Detection and Diagnostic Revenue (US$, Mn), (2017-2022)
Table 39. Aelian Biotechnology Corporate Summary
Table 40. Aelian Biotechnology CRISPR Gene Detection and Diagnostic Product Offerings
Table 41. Aelian Biotechnology CRISPR Gene Detection and Diagnostic Revenue (US$, Mn), (2017-2022)
Table 42. Vivlion Corporate Summary
Table 43. Vivlion CRISPR Gene Detection and Diagnostic Product Offerings
Table 44. Vivlion CRISPR Gene Detection and Diagnostic Revenue (US$, Mn), (2017-2022)
Table 45. Beckman Coulter Diagnostics Corporate Summary
Table 46. Beckman Coulter Diagnostics CRISPR Gene Detection and Diagnostic Product Offerings
Table 47. Beckman Coulter Diagnostics CRISPR Gene Detection and Diagnostic Revenue (US$, Mn), (2017-2022)
Table 48. Binx Health Corporate Summary
Table 49. Binx Health CRISPR Gene Detection and Diagnostic Product Offerings
Table 50. Binx Health CRISPR Gene Detection and Diagnostic Revenue (US$, Mn), (2017-2022)
Table 51. bioM?rieux Diagnostics Corporate Summary
Table 52. bioM?rieux Diagnostics CRISPR Gene Detection and Diagnostic Product Offerings
Table 53. bioM?rieux Diagnostics CRISPR Gene Detection and Diagnostic Revenue (US$, Mn), (2017-2022)
Table 54. Caspr Biotech Corporate Summary
Table 55. Caspr Biotech CRISPR Gene Detection and Diagnostic Product Offerings
Table 56. Caspr Biotech CRISPR Gene Detection and Diagnostic Revenue (US$, Mn), (2017-2022)
Table 57. Agilent Corporate Summary
Table 58. Agilent CRISPR Gene Detection and Diagnostic Product Offerings
Table 59. Agilent CRISPR Gene Detection and Diagnostic Revenue (US$, Mn), (2017-2022)
Table 60. Axxam Corporate Summary
Table 61. Axxam CRISPR Gene Detection and Diagnostic Product Offerings
Table 62. Axxam CRISPR Gene Detection and Diagnostic Revenue (US$, Mn), (2017-2022)
Table 63. ERS Genomics Corporate Summary
Table 64. ERS Genomics CRISPR Gene Detection and Diagnostic Product Offerings
Table 65. ERS Genomics CRISPR Gene Detection and Diagnostic Revenue (US$, Mn), (2017-2022)
Table 66. FASMAC Corporate Summary
Table 67. FASMAC CRISPR Gene Detection and Diagnostic Product Offerings
Table 68. FASMAC CRISPR Gene Detection and Diagnostic Revenue (US$, Mn), (2017-2022)
Table 69. Illumina Corporate Summary
Table 70. Illumina CRISPR Gene Detection and Diagnostic Product Offerings
Table 71. Illumina CRISPR Gene Detection and Diagnostic Revenue (US$, Mn), (2017-2022)
Table 72. Janssen Diagnostics Corporate Summary
Table 73. Janssen Diagnostics CRISPR Gene Detection and Diagnostic Product Offerings
Table 74. Janssen Diagnostics CRISPR Gene Detection and Diagnostic Revenue (US$, Mn), (2017-2022)
Table 75. Locus Biosciences Corporate Summary
Table 76. Locus Biosciences CRISPR Gene Detection and Diagnostic Product Offerings
Table 77. Locus Biosciences CRISPR Gene Detection and Diagnostic Revenue (US$, Mn), (2017-2022)
Table 78. Mammoth Biosciences Corporate Summary
Table 79. Mammoth Biosciences CRISPR Gene Detection and Diagnostic Product Offerings
Table 80. Mammoth Biosciences CRISPR Gene Detection and Diagnostic Revenue (US$, Mn), (2017-2022)
Table 81. NRGene Corporate Summary
Table 82. NRGene CRISPR Gene Detection and Diagnostic Product Offerings
Table 83. NRGene CRISPR Gene Detection and Diagnostic Revenue (US$, Mn), (2017-2022)
Table 84. Bio-Rad Laboratories, Inc Corporate Summary
Table 85. Bio-Rad Laboratories, Inc CRISPR Gene Detection and Diagnostic Product Offerings
Table 86. Bio-Rad Laboratories, Inc CRISPR Gene Detection and Diagnostic Revenue (US$, Mn), (2017-2022)
Table 87. 10x Genomics, Inc. Corporate Summary
Table 88. 10x Genomics, Inc. CRISPR Gene Detection and Diagnostic Product Offerings
Table 89. 10x Genomics, Inc. CRISPR Gene Detection and Diagnostic Revenue (US$, Mn), (2017-2022)
Table 1. CRISPR Gene Detection and Diagnostic Market Opportunities & Trends in Global Market
Table 2. CRISPR Gene Detection and Diagnostic Market Drivers in Global Market
Table 3. CRISPR Gene Detection and Diagnostic Market Restraints in Global Market
Table 4. Key Players of CRISPR Gene Detection and Diagnostic in Global Market
Table 5. Top CRISPR Gene Detection and Diagnostic Players in Global Market, Ranking by Revenue (2021)
Table 6. Global CRISPR Gene Detection and Diagnostic Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global CRISPR Gene Detection and Diagnostic Revenue Share by Companies, 2017-2022
Table 8. Global Companies CRISPR Gene Detection and Diagnostic Product Type
Table 9. List of Global Tier 1 CRISPR Gene Detection and Diagnostic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 CRISPR Gene Detection and Diagnostic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - CRISPR Gene Detection and Diagnostic Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - CRISPR Gene Detection and Diagnostic Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - CRISPR Gene Detection and Diagnostic Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - CRISPR Gene Detection and Diagnostic Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global CRISPR Gene Detection and Diagnostic Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global CRISPR Gene Detection and Diagnostic Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2023-2028
Table 30. Roche Molecular Diagnostics Corporate Summary
Table 31. Roche Molecular Diagnostics CRISPR Gene Detection and Diagnostic Product Offerings
Table 32. Roche Molecular Diagnostics CRISPR Gene Detection and Diagnostic Revenue (US$, Mn), (2017-2022)
Table 33. Sherlock Biosciences Corporate Summary
Table 34. Sherlock Biosciences CRISPR Gene Detection and Diagnostic Product Offerings
Table 35. Sherlock Biosciences CRISPR Gene Detection and Diagnostic Revenue (US$, Mn), (2017-2022)
Table 36. Thermo Fisher Scientific Inc. Corporate Summary
Table 37. Thermo Fisher Scientific Inc. CRISPR Gene Detection and Diagnostic Product Offerings
Table 38. Thermo Fisher Scientific Inc. CRISPR Gene Detection and Diagnostic Revenue (US$, Mn), (2017-2022)
Table 39. Aelian Biotechnology Corporate Summary
Table 40. Aelian Biotechnology CRISPR Gene Detection and Diagnostic Product Offerings
Table 41. Aelian Biotechnology CRISPR Gene Detection and Diagnostic Revenue (US$, Mn), (2017-2022)
Table 42. Vivlion Corporate Summary
Table 43. Vivlion CRISPR Gene Detection and Diagnostic Product Offerings
Table 44. Vivlion CRISPR Gene Detection and Diagnostic Revenue (US$, Mn), (2017-2022)
Table 45. Beckman Coulter Diagnostics Corporate Summary
Table 46. Beckman Coulter Diagnostics CRISPR Gene Detection and Diagnostic Product Offerings
Table 47. Beckman Coulter Diagnostics CRISPR Gene Detection and Diagnostic Revenue (US$, Mn), (2017-2022)
Table 48. Binx Health Corporate Summary
Table 49. Binx Health CRISPR Gene Detection and Diagnostic Product Offerings
Table 50. Binx Health CRISPR Gene Detection and Diagnostic Revenue (US$, Mn), (2017-2022)
Table 51. bioM?rieux Diagnostics Corporate Summary
Table 52. bioM?rieux Diagnostics CRISPR Gene Detection and Diagnostic Product Offerings
Table 53. bioM?rieux Diagnostics CRISPR Gene Detection and Diagnostic Revenue (US$, Mn), (2017-2022)
Table 54. Caspr Biotech Corporate Summary
Table 55. Caspr Biotech CRISPR Gene Detection and Diagnostic Product Offerings
Table 56. Caspr Biotech CRISPR Gene Detection and Diagnostic Revenue (US$, Mn), (2017-2022)
Table 57. Agilent Corporate Summary
Table 58. Agilent CRISPR Gene Detection and Diagnostic Product Offerings
Table 59. Agilent CRISPR Gene Detection and Diagnostic Revenue (US$, Mn), (2017-2022)
Table 60. Axxam Corporate Summary
Table 61. Axxam CRISPR Gene Detection and Diagnostic Product Offerings
Table 62. Axxam CRISPR Gene Detection and Diagnostic Revenue (US$, Mn), (2017-2022)
Table 63. ERS Genomics Corporate Summary
Table 64. ERS Genomics CRISPR Gene Detection and Diagnostic Product Offerings
Table 65. ERS Genomics CRISPR Gene Detection and Diagnostic Revenue (US$, Mn), (2017-2022)
Table 66. FASMAC Corporate Summary
Table 67. FASMAC CRISPR Gene Detection and Diagnostic Product Offerings
Table 68. FASMAC CRISPR Gene Detection and Diagnostic Revenue (US$, Mn), (2017-2022)
Table 69. Illumina Corporate Summary
Table 70. Illumina CRISPR Gene Detection and Diagnostic Product Offerings
Table 71. Illumina CRISPR Gene Detection and Diagnostic Revenue (US$, Mn), (2017-2022)
Table 72. Janssen Diagnostics Corporate Summary
Table 73. Janssen Diagnostics CRISPR Gene Detection and Diagnostic Product Offerings
Table 74. Janssen Diagnostics CRISPR Gene Detection and Diagnostic Revenue (US$, Mn), (2017-2022)
Table 75. Locus Biosciences Corporate Summary
Table 76. Locus Biosciences CRISPR Gene Detection and Diagnostic Product Offerings
Table 77. Locus Biosciences CRISPR Gene Detection and Diagnostic Revenue (US$, Mn), (2017-2022)
Table 78. Mammoth Biosciences Corporate Summary
Table 79. Mammoth Biosciences CRISPR Gene Detection and Diagnostic Product Offerings
Table 80. Mammoth Biosciences CRISPR Gene Detection and Diagnostic Revenue (US$, Mn), (2017-2022)
Table 81. NRGene Corporate Summary
Table 82. NRGene CRISPR Gene Detection and Diagnostic Product Offerings
Table 83. NRGene CRISPR Gene Detection and Diagnostic Revenue (US$, Mn), (2017-2022)
Table 84. Bio-Rad Laboratories, Inc Corporate Summary
Table 85. Bio-Rad Laboratories, Inc CRISPR Gene Detection and Diagnostic Product Offerings
Table 86. Bio-Rad Laboratories, Inc CRISPR Gene Detection and Diagnostic Revenue (US$, Mn), (2017-2022)
Table 87. 10x Genomics, Inc. Corporate Summary
Table 88. 10x Genomics, Inc. CRISPR Gene Detection and Diagnostic Product Offerings
Table 89. 10x Genomics, Inc. CRISPR Gene Detection and Diagnostic Revenue (US$, Mn), (2017-2022)
LIST OF FIGURES
Figure 1. CRISPR Gene Detection and Diagnostic Segment by Type in 2021
Figure 2. CRISPR Gene Detection and Diagnostic Segment by Application in 2021
Figure 3. Global CRISPR Gene Detection and Diagnostic Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global CRISPR Gene Detection and Diagnostic Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global CRISPR Gene Detection and Diagnostic Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by CRISPR Gene Detection and Diagnostic Revenue in 2021
Figure 8. By Type - Global CRISPR Gene Detection and Diagnostic Revenue Market Share, 2017-2028
Figure 9. By Application - Global CRISPR Gene Detection and Diagnostic Revenue Market Share, 2017-2028
Figure 10. By Region - Global CRISPR Gene Detection and Diagnostic Revenue Market Share, 2017-2028
Figure 11. By Country - North America CRISPR Gene Detection and Diagnostic Revenue Market Share, 2017-2028
Figure 12. US CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 13. Canada CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe CRISPR Gene Detection and Diagnostic Revenue Market Share, 2017-2028
Figure 16. Germany CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 17. France CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 19. Italy CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 20. Russia CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia CRISPR Gene Detection and Diagnostic Revenue Market Share, 2017-2028
Figure 24. China CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 25. Japan CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 28. India CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America CRISPR Gene Detection and Diagnostic Revenue Market Share, 2017-2028
Figure 30. Brazil CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa CRISPR Gene Detection and Diagnostic Revenue Market Share, 2017-2028
Figure 33. Turkey CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 34. Israel CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 36. UAE CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 37. Roche Molecular Diagnostics CRISPR Gene Detection and Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Sherlock Biosciences CRISPR Gene Detection and Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Thermo Fisher Scientific Inc. CRISPR Gene Detection and Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Aelian Biotechnology CRISPR Gene Detection and Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Vivlion CRISPR Gene Detection and Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Beckman Coulter Diagnostics CRISPR Gene Detection and Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Binx Health CRISPR Gene Detection and Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. bioM?rieux Diagnostics CRISPR Gene Detection and Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Caspr Biotech CRISPR Gene Detection and Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Agilent CRISPR Gene Detection and Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Axxam CRISPR Gene Detection and Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. ERS Genomics CRISPR Gene Detection and Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. FASMAC CRISPR Gene Detection and Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Illumina CRISPR Gene Detection and Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Janssen Diagnostics CRISPR Gene Detection and Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Locus Biosciences CRISPR Gene Detection and Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Mammoth Biosciences CRISPR Gene Detection and Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. NRGene CRISPR Gene Detection and Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Bio-Rad Laboratories, Inc CRISPR Gene Detection and Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. 10x Genomics, Inc. CRISPR Gene Detection and Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 1. CRISPR Gene Detection and Diagnostic Segment by Type in 2021
Figure 2. CRISPR Gene Detection and Diagnostic Segment by Application in 2021
Figure 3. Global CRISPR Gene Detection and Diagnostic Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global CRISPR Gene Detection and Diagnostic Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global CRISPR Gene Detection and Diagnostic Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by CRISPR Gene Detection and Diagnostic Revenue in 2021
Figure 8. By Type - Global CRISPR Gene Detection and Diagnostic Revenue Market Share, 2017-2028
Figure 9. By Application - Global CRISPR Gene Detection and Diagnostic Revenue Market Share, 2017-2028
Figure 10. By Region - Global CRISPR Gene Detection and Diagnostic Revenue Market Share, 2017-2028
Figure 11. By Country - North America CRISPR Gene Detection and Diagnostic Revenue Market Share, 2017-2028
Figure 12. US CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 13. Canada CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe CRISPR Gene Detection and Diagnostic Revenue Market Share, 2017-2028
Figure 16. Germany CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 17. France CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 19. Italy CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 20. Russia CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia CRISPR Gene Detection and Diagnostic Revenue Market Share, 2017-2028
Figure 24. China CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 25. Japan CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 28. India CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America CRISPR Gene Detection and Diagnostic Revenue Market Share, 2017-2028
Figure 30. Brazil CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa CRISPR Gene Detection and Diagnostic Revenue Market Share, 2017-2028
Figure 33. Turkey CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 34. Israel CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 36. UAE CRISPR Gene Detection and Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 37. Roche Molecular Diagnostics CRISPR Gene Detection and Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Sherlock Biosciences CRISPR Gene Detection and Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Thermo Fisher Scientific Inc. CRISPR Gene Detection and Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Aelian Biotechnology CRISPR Gene Detection and Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Vivlion CRISPR Gene Detection and Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Beckman Coulter Diagnostics CRISPR Gene Detection and Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Binx Health CRISPR Gene Detection and Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. bioM?rieux Diagnostics CRISPR Gene Detection and Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Caspr Biotech CRISPR Gene Detection and Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Agilent CRISPR Gene Detection and Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Axxam CRISPR Gene Detection and Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. ERS Genomics CRISPR Gene Detection and Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. FASMAC CRISPR Gene Detection and Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Illumina CRISPR Gene Detection and Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Janssen Diagnostics CRISPR Gene Detection and Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Locus Biosciences CRISPR Gene Detection and Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Mammoth Biosciences CRISPR Gene Detection and Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. NRGene CRISPR Gene Detection and Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Bio-Rad Laboratories, Inc CRISPR Gene Detection and Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. 10x Genomics, Inc. CRISPR Gene Detection and Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
